Cleerly to Present Late-Breaking Clinical Trial Results on Cardiovascular Risk in Women at ACC.25
Cleerly to Present Late-Breaking Findings and Participate in Key ACC.25 Sessions
Cleerly to Present Late-Breaking Findings and Participate in Key ACC.25 Sessions
Cleerly will demonstrate its FDA-cleared heart image analyses using mobile scanners in collaboration with Corazon Imaging and Philips